<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03736642</url>
  </required_header>
  <id_info>
    <org_study_id>18CH109</org_study_id>
    <secondary_id>2018-A01731-54</secondary_id>
    <nct_id>NCT03736642</nct_id>
  </id_info>
  <brief_title>Study of the Microbiological Profile of Stool in Patients With Anorexia Nervosa</brief_title>
  <acronym>ANOSTOOL</acronym>
  <official_title>Study of the Microbiological Profile of Stool in Patients With Anorexia Nervosa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anorexia nervosa is an eating disorder whose symptomatology induces a modification of the&#xD;
      intestinal microbiota. To date, studies have shown variable profiles without linking them to&#xD;
      metabolic and neuropsychological energy phenotyping. This intestinal dysbiosis could be&#xD;
      involved in the maintenance of the disorders. Bidirectional communication channels exist&#xD;
      between the microbiota, the intestine and the brain. Anomalies in these pathways could&#xD;
      explain the impact of the microbiota on the pathophysiology of anorexia nervosa. Therapeutic&#xD;
      interventions would then be possible to restore the microbiota in anorexia nervosa and&#xD;
      influence the treatment of this disease. This study aims to explore the hypothesis of&#xD;
      disruption of the microbiota-intestinal-brain axis transversely and measuring the intestinal&#xD;
      microbiota, urinary metabolome, biological factors nutritional, immunological and&#xD;
      physiological plasma plasma of the intestine, and finally, the psychological dimensions&#xD;
      characteristic of anorexia nervosa.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    never started&#xD;
  </why_stopped>
  <start_date type="Actual">May 15, 2019</start_date>
  <completion_date type="Actual">May 15, 2019</completion_date>
  <primary_completion_date type="Actual">May 15, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>determination of bacterial microbiological profile by 16s sequencing of stool samples</measure>
    <time_frame>at inclusion</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determination of the metabolomic profile</measure>
    <time_frame>at inclusion</time_frame>
    <description>evaluated by mass spectrometry (MS/MS) of urine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurocognitive evaluation</measure>
    <time_frame>at 2 months</time_frame>
    <description>evaluated with questionnaire go-nogo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurocognitive evaluation</measure>
    <time_frame>at 2 months</time_frame>
    <description>evaluated with questionnaire of flexibility</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurocognitive evaluation</measure>
    <time_frame>at 2 months</time_frame>
    <description>evaluated with questionnaire : food troop</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurocognitive evaluation</measure>
    <time_frame>at 2 months</time_frame>
    <description>evaluated with questionnaires : implicit and explicit evaluation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychometric scaling for thymic evaluation</measure>
    <time_frame>at 2 months</time_frame>
    <description>evaluated with questionnaire : Child Depression Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychometric scaling for thymic evaluation</measure>
    <time_frame>at 2 months</time_frame>
    <description>evaluated with questionnaire : Hamilton Depression Rating Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determination of the plasma profile of intestinal physiology markers and immunological markers</measure>
    <time_frame>at inclusion</time_frame>
    <description>Intestinal permeability markers: ASCA, antiglycan, anti GP2 IgG/IgA, calprotectin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determination of the plasma profile of intestinal physiology markers and immunological markers</measure>
    <time_frame>at inclusion</time_frame>
    <description>immunoglobulin repertoire: A and M, inflammatory molecules: C-reactive protein</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determination of the plasma profile of intestinal physiology markers and immunological markers</measure>
    <time_frame>at inclusion</time_frame>
    <description>circulating interleukins of the Th17 profile: IL17, IL23, IL6, IL1β, IL 22, IL21, IL33, IL31, TNFα, IFNγ, IL9, IL10, IL4.</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Anorexia Nervosa</condition>
  <condition>Eating Disorder</condition>
  <arm_group>
    <arm_group_label>restrictive anorexia nervosa with hunger</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>restrictive anorexia nervosa without hunger</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>constitutional thinness</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>control subjects without eating disorders</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>blood sampling</intervention_name>
    <description>12 ml sample</description>
    <arm_group_label>constitutional thinness</arm_group_label>
    <arm_group_label>control subjects without eating disorders</arm_group_label>
    <arm_group_label>restrictive anorexia nervosa with hunger</arm_group_label>
    <arm_group_label>restrictive anorexia nervosa without hunger</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>stool sampling</intervention_name>
    <description>20 g sample</description>
    <arm_group_label>constitutional thinness</arm_group_label>
    <arm_group_label>control subjects without eating disorders</arm_group_label>
    <arm_group_label>restrictive anorexia nervosa with hunger</arm_group_label>
    <arm_group_label>restrictive anorexia nervosa without hunger</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>urine sampling</intervention_name>
    <description>18 ml sample</description>
    <arm_group_label>constitutional thinness</arm_group_label>
    <arm_group_label>control subjects without eating disorders</arm_group_label>
    <arm_group_label>restrictive anorexia nervosa with hunger</arm_group_label>
    <arm_group_label>restrictive anorexia nervosa without hunger</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>neuropsychological tests</intervention_name>
    <description>Go-nogo&#xD;
flexibility&#xD;
food stroop&#xD;
implicit and explicit evaluation&#xD;
Child Depression Inventory&#xD;
Hamilton Depression Rating Scale</description>
    <arm_group_label>constitutional thinness</arm_group_label>
    <arm_group_label>control subjects without eating disorders</arm_group_label>
    <arm_group_label>restrictive anorexia nervosa with hunger</arm_group_label>
    <arm_group_label>restrictive anorexia nervosa without hunger</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      -  20 g of stool&#xD;
&#xD;
        -  18 ml of urines&#xD;
&#xD;
        -  12 ml of blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        -  anorexia nervosa with and without hunger&#xD;
&#xD;
          -  constitutional leanness&#xD;
&#xD;
          -  control subjects&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria common to all four groups&#xD;
&#xD;
          -  Patient affiliated or entitled to a social security scheme&#xD;
&#xD;
          -  Patient who received informed information about the study&#xD;
&#xD;
          -  Patient does not object to participating in the study&#xD;
&#xD;
        Inclusion criteria specific to mental anorexia&#xD;
&#xD;
          -  BMI between 13 and 17.5 kg/m2&#xD;
&#xD;
          -  Diagnostic and Statistical Manual of Mental Disorders IV restrictive anorexia nervosa&#xD;
             diagnostic criteria&#xD;
&#xD;
          -  Evolution of the troubles since less than 1 year.&#xD;
&#xD;
          -  with feeling of hunger: &quot;hunger&quot; = total score on the 24-hour hunger scale &gt; 15 and&#xD;
             presence of the three prandial peaks (score = 3)&#xD;
&#xD;
          -  having lost the feeling of hunger: &quot;not hungry&quot; = total score on the 24-hour hunger&#xD;
             scale ≤ 5 and absence of the three prandial peaks (score ≤ 2)&#xD;
&#xD;
        Inclusion criteria specific to constitutionally thin patients&#xD;
&#xD;
          -  BMI between 13 and 17.5 kg/m2&#xD;
&#xD;
          -  Stable weight for at least 3 months&#xD;
&#xD;
          -  No eating disorder&#xD;
&#xD;
          -  No markers of undernutrition&#xD;
&#xD;
        Inclusion criteria specific to normal weight subjects&#xD;
&#xD;
          -  20 kg/m2 ≤ BMI ≤ 25 kg/m2&#xD;
&#xD;
          -  Stable weight for at least 3 months&#xD;
&#xD;
          -  No eating disorder&#xD;
&#xD;
          -  No markers of undernutrition&#xD;
&#xD;
        Non-inclusion criteria for all subjects :&#xD;
&#xD;
          -  Antibiotic treatment during the 2 months preceding the sampling.&#xD;
&#xD;
          -  History of immune system/autoimmune disease: Immune deficiency, Crohn's disease,&#xD;
             systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, psoriasis,&#xD;
             Behçet's disease, celiac disease, type I diabetes.&#xD;
&#xD;
          -  History of metabolic pathology: intestinal malabsorptive disease&#xD;
&#xD;
          -  Medical or surgical history deemed by the investigator to be incompatible with this&#xD;
             study.&#xD;
&#xD;
          -  Severe progressive condition other&#xD;
&#xD;
          -  Pregnant woman&#xD;
&#xD;
          -  Majors under guardianship or subjects deprived of their liberty by judicial or&#xD;
             administrative decision&#xD;
&#xD;
          -  Ongoing psychotropic treatment&#xD;
&#xD;
          -  Progressive diarrhea (Bristol Type V and VI)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>only female</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Natacha GERMAIN</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Saint Etienne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chu Saint-Etienne</name>
      <address>
        <city>Saint-Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>November 2, 2018</study_first_submitted>
  <study_first_submitted_qc>November 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2018</study_first_posted>
  <last_update_submitted>July 28, 2020</last_update_submitted>
  <last_update_submitted_qc>July 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>stool</keyword>
  <keyword>constitutional thinness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anorexia</mesh_term>
    <mesh_term>Feeding and Eating Disorders</mesh_term>
    <mesh_term>Anorexia Nervosa</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

